EPA Moves Forward Toward Test Rule for BPA; Effects on Humans Still Primarily Outside Scope of Process
EPA made further progress this week in its efforts to move forward with a potential Bisphenol-A (BPA) Test Rule, publishing an Advance Notice of Proposed Rulemaking (ANPRM) in the Federal Register. Overall this progress is good news, though it’s not without its flaws.
EPA completed a draft of the ANPRM in December and sent it over to the Office of Information and Regulatory Affairs (OIRA) for review, pursuant to Executive Order 12866. Despite a 10-working-day deadline for review of ANPRMs, OIRA spent more than seven months on its review. OIRA’s edits were also released this week and placed in EPA’s docket.
Mind you, this ANPRM is not a notice for the actual BPA Test Rule, but rather a solicitation for comments and input on whether such a rule is necessary, and, if so, what procedures, target test sites, testing standards, and protocols would best serve the intended purpose of such a rule. The actual chemical test rule, authorized by section 4 of the Toxic Substances Control Act (TSCA), would impose specific exposure monitoring and toxicity effects testing requirements on the processors, manufacturers, and importers of the subject chemical. For example, a sewage treatment plant might have to monitor how much BPA remains in the post-treatment sewage sludge that it distributes to farms, incinerators, and landfills, or a plastics manufacturer may have to conduct testing (most likely through a third party) on BPA’s low-dose toxicity effects on certain aquatic populations.
Assuming that EPA determines
Holding its Legal (and Parental) Ground: EPA Responds to the American Chemistry Council's Request for Correction of the BPA Action Plan
Being a parent is not easy, but some of the most difficult moments arise when you know what needs to be done to protect your child and your child has other sentiments. Call it a temper tantrum, a battle of wills, or disobedience, it all evokes a sense of frustration, exhaustion, and, let’s face it, self-doubt. There is that brief moment when you think to yourself, “Wouldn’t it just be easier to let them have their way? Maybe I am being too harsh
New CPR White Paper Tackles Industry Myths About BPA
by Lena Pons | June 02, 2011
For the last two decades, scientists have amassed evidence that bisphenol A (BPA) poses a threat to human health. BPA is a chemical used in the manufacture of polycarbonate plastic, can liners for food and beverages, and thermal paper used for register receipts. It is used in so many applications that the Centers for Disease Control and Prevention found traces of BPA in 93 percent of people it tested. Although scientists have targeted BPA as a public health concern, plastics
Scientific Uncertainty About BPA Is the Inevitable Result of a Broken TSCA
by Matt Shudtz | September 08, 2010
In Tuesday's New York Times story, “In a Feast of Data on BPA Plastic, No Final Answer,” Denise Grady characterizes the continued development of new studies about the endocrine disrupting chemical as yet another dispute between environmentalists and chemical manufacturers over a ubiquitous chemical with uncertain health effects. While her assessment of the state of the science is accurate, she expends thousands of words parsing the uncertainty and profiling the scientists who’ve made it their work to reduce the uncertainty without
American Chemistry Council's Request for Correction on BPA Action Plan Exceeds the Limits of the Data Quality Act
by Lena Pons | August 06, 2010
The American Chemistry Council (ACC), a trade association that represents chemical industry interests and is heavily connected to the plastics industry, filed a Request for Correction Monday on the EPA's Chemical Action Plan for Bisphenol A (BPA). The request, filed under a provision of the Data Quality Act (also referred to as the Information Quality Act), is truly astonishing and bears noting. In addition to standard requests that EPA statements be toned down or removed due to conflicting studies, ACC makes several
EPA's Coming Announcement on BPA
In response to a question at a National Press Club appearance on Monday, Lisa Jackson said that the EPA would be finalizing an action plan on BPA in the "very near future." As I noted here in January, the EPA had announced in September that it would be releasing action plans on a number of chemicals, including BPA, but when the first group of plans was released in late December, BPA was not among them. I raised a red flag
Science Versus Theology: The BPA Debate Continues
This post, by Sarah Vogel, is cross-posted from The Pump Handle. If you thought the scientific debate about bisphenol A was over or even quieting down, you haven’t been reading the latest issues of Toxicological Sciences. (What are you doing with your spare time?) Last month in an editorial piece published in the journal, Richard Sharpe queried: “Is It Time to End Concerns over the Estrogenic Effects of Bisphenol A?” His answer was an unequivocal ‘yes’, based on the latest
In OIRA Meeting on BPA, 13 of 19 Studies Presented Funded by Industry
by Ben Somberg | February 15, 2010
The Milwaukee Journal-Sentinel had its latest article on BPA this weekend, this time looking at the role of the December 22 meeting between the industry and OIRA. Writer Meg Kissinger contrasts the forceful EPA statements on BPA from last year with the lack of an EPA action plan on the chemical now. As for the documents presented to OIRA at the meeting, The Journal Sentinel reviewed the list and found 13 of the 19 papers and presentations cited were paid
Next Up on BPA: EPA's Chemical Action Plan?
FDA scientists have had a chance to develop an assessment of the risks of BPA in food contact applications using a fuller body of low-dose studies and concluded last week that there’s some concern about the potential effects of BPA on the brain, behavior, and prostate gland of fetuses, infants and children (for a helpful analysis of the context of FDA’s decision, see Sarah Vogel’s post at The Pump Handle). Now, it’s time to look at what EPA is doing
FDA Needs More Time for its Report on BPA
by Matt Shudtz | December 01, 2009
Yesterday came and went with no announcement from the FDA on the safety of BPA in food packaging. The agency had created a self-imposed November 30 deadline for releasing a new finding, and in the intervening months, a number of new studies on the health effects of BPA have been released and FDA has brought in an outside expert to head up the review. These developments have understandably slowed the review process. The question before FDA is whether BPA is
Update on BPA and the FDA
On Monday, the big news out of FDA was the announcement that they’re going to publish a new assessment of the risks posed by BPA in food packaging, due out by the end of November. Jesse Goodman, FDA’s Chief Scientist, made the announcement at a meeting of the agency’s Science Board, which also heard two presentations by scientists from different offices within FDA working on the new assessment. Last year, FDA formed a task force to assess the risks of